Coya Therapeutics, Inc. Amortization of Debt Issuance Costs
Coya Therapeutics, Inc. (COYA) reported Amortization of Debt Issuance Costs of $997.37 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2024-03-19.
Discontinued › Operating Expenses
us-gaap:AmortizationOfFinancingCosts · last filed 2024-03-19
- Coya Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2022-12-31 was $0.00.
- Coya Therapeutics, Inc. amortization of debt issuance costs for the quarter ending 2022-09-30 was $0.00.
- Coya Therapeutics, Inc. amortization of debt issuance costs for fiscal 2022 was $997.37K.
| Period end | Amortization of Debt Issuance Costs 3 month | Amortization of Debt Issuance Costs 6 month | Amortization of Debt Issuance Costs 9 month | Amortization of Debt Issuance Costs 12 month |
|---|---|---|---|---|
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $0.00 derived: sum of 2 quarters · filed 2024-03-19 | $997.37K 10-K · filed 2024-03-19 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | $997.37K 10-Q · filed 2023-11-08 | ||
| 2022-06-30 | $997.37K 10-Q · filed 2023-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |